Department of Medicine, Tokai University School of Medicine, Shimokasuya 143, Isehara, Kanagawa, 259-1193, Japan.
Endocr Pathol. 2013 Sep;24(3):144-8. doi: 10.1007/s12022-013-9252-0.
Succinate dehydrogenase subunit B gene (SDHB) is associated with the development of hereditary paraganglioma (PGL) and pheochromocytoma (PCC). Here we describe a novel germline mutation in SDHB in a 69-year-old Japanese woman with a posterior mediastinal PGL. We summarize the clinical presentation, diagnostic work-up, and pathological features of a patient with a posterior mediastinal PGL and review the pertinent literature. Direct sequencing of SDHB and SDHD was performed. The patient presented with a posterior mediastinal tumor and was normotensive. She underwent abdominal tumor resection at the age of 38 years, but clinical and pathological diagnoses were unknown. She had no family history of hypertension, PGL, or PCC. Imaging studies suggested that the tumor was neurogenic. Endocrinological examinations showed normal plasma catecholamine levels. The tumor was completely removed without metastasis. Pathological findings confirmed PGL. Immunohistochemical staining showed that the tumor cells were positive for chromogranin A, synaptophysin, and CD56, and the Ki67 index was low (<1 %). The patient has not experienced recurrence or metastasis for the last 5 years. DNA sequencing revealed a novel P236S (c.843 C > T) mutation in SDHB. The P236S germline mutation in SDHB was associated with posterior mediastinal PGL. Strict follow-up of the patient is necessary because the SDHB mutation may be related to malignancy.
琥珀酸脱氢酶亚基 B 基因(SDHB)与遗传性副神经节瘤(PGL)和嗜铬细胞瘤(PCC)的发生有关。在这里,我们描述了一位 69 岁日本女性后纵隔 PGL 中 SDHB 的一种新的种系突变。我们总结了一位后纵隔 PGL 患者的临床表现、诊断检查和病理特征,并复习了相关文献。对 SDHB 和 SDHD 进行了直接测序。患者表现为后纵隔肿瘤,血压正常。她在 38 岁时接受了腹部肿瘤切除术,但临床和病理诊断不详。她没有高血压、PGL 或 PCC 的家族史。影像学研究提示肿瘤为神经源性。内分泌检查显示血浆儿茶酚胺水平正常。肿瘤无转移而被完全切除。病理检查证实为 PGL。免疫组织化学染色显示肿瘤细胞对嗜铬粒蛋白 A、突触素和 CD56 呈阳性,Ki67 指数低(<1%)。患者在过去 5 年内未出现复发或转移。DNA 测序显示 SDHB 中的一个新的 P236S(c.843 C > T)突变。SDHB 中的 P236S 种系突变与后纵隔 PGL 有关。由于 SDHB 突变可能与恶性肿瘤有关,因此需要对患者进行严格随访。